GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹563 Cr | ₹475 Cr | ₹29 Cr | ₹-251 Cr | ₹-119 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹563 Cr |
| Mar2025 | ₹475 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹-251 Cr |
| Mar2022 | ₹-119 Cr |
How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹563 Cr | 18.65 | |
| Mar2025 | ₹475 Cr | 1,523.94 | |
| Mar2024 | ₹29 Cr | Positive | |
| Mar2023 | ₹-251 Cr | Negative | |
| Mar2022 | ₹-119 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,361.9 Cr | 0.7% | -7.4% | -2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.7% |
-7.4% |
-2.6% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses